Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.63	20.02	28.92	48.26	30.44	17.29
Cash & Short-Term Investments	13.63	20.02	28.92	48.26	30.44	17.29
Cash Growth	-61.45%	-30.78%	-40.07%	58.56%	76.06%	-23.49%
Receivables	1.54	0.51	0.47	-	10	-
Prepaid Expenses	0.72	0.73	0.72	0.7	0.92	0.72
Restricted Cash	-	-	-	0.16	0.1	0.1
Other Current Assets	0.08	0.01	0.01	0.28	0.68	0.01
Total Current Assets	15.96	21.27	30.12	49.4	42.14	18.12
Property, Plant & Equipment	3.67	3.82	3.87	1.87	0.61	0.94
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.16	0.26
Total Assets	19.67	25.13	34.02	51.3	42.9	19.32
Accounts Payable	1.91	1.45	2.21	1.05	0.94	2
Accrued Expenses	2.72	2.97	4.17	4.18	3.31	1.58
Current Portion of Long-Term Debt	-	-	-	-	-	0.99
Current Portion of Leases	0.38	0.38	0.36	0.35	0.39	0.37
Current Unearned Revenue	-	-	0.08	0.21	-	5
Total Current Liabilities	5.01	4.79	6.81	5.78	4.64	9.94
Long-Term Debt	53.44	51.77	41.99	33.98	-	-
Long-Term Leases	0.24	0.33	0.65	0.94	0.29	0.62
Other Long-Term Liabilities	6.89	7.09	0.48	-	-	-
Total Liabilities	65.58	63.98	49.93	40.7	4.93	10.56
Common Stock	0.08	0.08	0.06	0.06	0.06	0.05
Additional Paid-In Capital	317.51	316.34	304.95	298.98	293.41	264.58
Retained Earnings	-363.5	-355.28	-320.92	-288.44	-255.49	-255.87
Total Common Equity	-45.91	-38.86	-15.91	10.61	37.98	8.76
Shareholders' Equity	-45.91	-38.86	-15.91	10.61	37.98	8.76
Total Liabilities & Equity	19.67	25.13	34.02	51.3	42.9	19.32
Total Debt	54.06	52.47	43	35.26	0.68	1.98
Net Cash (Debt)	-40.43	-32.45	-14.08	13	29.76	15.31
Net Cash Growth	-	-	-	-56.33%	94.43%	-5.43%
Net Cash Per Share	-0.54	-0.44	-0.23	0.22	0.50	0.33
Filing Date Shares Outstanding	77.71	77.14	74.72	61.36	60.15	57.42
Total Common Shares Outstanding	77.27	76.58	62.85	60.64	59.72	51.86
Working Capital	10.95	16.48	23.31	43.62	37.5	8.18
Book Value Per Share	-0.59	-0.51	-0.25	0.17	0.64	0.17
Tangible Book Value	-45.91	-38.86	-15.91	10.61	37.98	8.76
Tangible Book Value Per Share	-0.59	-0.51	-0.25	0.17	0.64	0.17
Machinery	2.03	2.03	0.85	0.61	0.53	0.53
Construction In Progress	1.88	1.87	2.59	0.53	-	-
Leasehold Improvements	0.48	0.48	0.48	0.48	0.67	0.67

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q